Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
Status: | Completed |
---|---|
Conditions: | Ovarian Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | August 2002 |
End Date: | February 2006 |
Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma
The purpose of this study is to determine the safety and efficacy of this regimen in women
with ovarian or peritoneal cancer
with ovarian or peritoneal cancer
Inclusion Criteria:
- Recurrent ovarian or peritoneal cancer
Exclusion Criteria:
- No prior chemotherapy
We found this trial at
1
site
600 Highland Ave
Madison, Wisconsin 53792
Madison, Wisconsin 53792
(608) 263-6400
University of Wisconsin Hospital and Clinics UW Health strives to meet the health needs of...
Click here to add this to my saved trials